{
  "report_rows": [
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.85B vs. cons $1.814B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "U.S. Commercial Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$740M vs. cons $718M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.40 vs. cons $0.351",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 2026 Revenue (Q3 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.96B mid vs. cons ~$1.95B",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY 2026 Revenue (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$7.90B mid vs. cons $7.740B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 U.S. Commercial Revenue (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide >=3.40B vs. cons $3.221B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Adj. Operating Income (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$4.65B mid vs. cons $4.565B",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 7.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 FY raise drives modest estimate revisions upward; de-rated stock has room to recover; positive day-0 Archetype B quarters consistently followed through",
  "day5_confidence": "MEDIUM"
}